1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Injectable Drug Delivery Market:By Devices, Therapeutics & Formulations [Self-Injection Devices (Pen, Needle Free & Auto Injectors), Auto-Immune Diseases, Diabetes, Oncology, Hormonal Disorders, Liposomes, Microspheres, Nanoparticles, Polymeric Micelles]

The Global Injectable Drug Delivery Devices Market has been analyzed with respect to the demand for devices from different countries across the globe. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2020. The drug injection devices market has been segmented into conventional injectors and self-injection devices broadly. Similarly the drug formulations market has been segmented into the conventional drugs and novel drugs segments. The therapeutic areas are further segmented and analyzed in this report.

While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to grow at 16.6% during 2013 – 2018. Conventional injection devices hold around 87% market share currently but this is expected to decrease to around 83% by 2018, as the use of self-injection devices increases in the next 5 years.

The global injectable drug delivery devices market is expected to increase from around $ 11.6 bn in 2013 to around $ 17.5 bn in 2018. Self-injection devices are expected to grow at the highest growth rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period 2013 – 2018.

Analyzing the competitive landscape of the global conventional injectable devices market for 2012 IndustryARC is of the opinion that Becton Dickinson & Co. had the top position with a market share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two companies along with Terumo Corporation and Schott AG together held market share of around 85%.

Table Of Contents

Injectable Drug Delivery Market:By Devices, Therapeutics and Formulations [Self-Injection Devices (Pen, Needle Free and Auto Injectors), Auto-Immune Diseases, Diabetes, Oncology, Hormonal Disorders, Liposomes, Microspheres, Nanoparticles, Polymeric Micelles]
1. Market Overview

2. Executive Summary

3. Market Landscape

3.1. Market Share Analysis

3.2. Comparative Analysis

3.2.1. Product Benchmarking

3.2.2. End user profiling

3.2.3. Patent Analysis

3.2.4. Top 5 Financials Analysis

4. Global Injectable Drug Delivery - Market Forces

4.1. Market Drivers

4.1.1. Inherent Use Case Scenario of IDD Devices With Biologics

4.1.2. Increase in Global Diabetic Population and Usage of Insulin Pens

4.1.3. Others

4.2. Market Constraints

4.2.1. Infection Risks And Government Laws

4.2.2. Others

4.3. Market Challenges

4.3.1. Higher Manufacturing Standards Needed to Avoid Product Recalls

4.3.2. Others

4.4. Attractiveness of the Industry

4.4.1. Power of Suppliers

4.4.2. Power of Customers

4.4.3. Threat of New entrants

4.4.4. Threat of Substitution

4.4.5. Degree of Competition

5. Global Injectable Drug Delivery Market- Strategic Analysis

5.1. Value Chain Analysis

5.2. Opportunities Analysis

5.3. Product/Market Life Cycle Analysis

6. Global Injectable Drug Delivery Market - By Type

6.1. Pharmaceutical Drug Formulations

6.2. By Device

6.2.1. Conventional Devices

6.2.2. Auto Injector Devices

6.2.3. Self Injector Devices

6.2.4. Pen Injectors

6.2.5. Needle Free Injector Devices

6.3. Others

7. Global Injectable Drug Delivery Market - By Type of Diseases

7.1. Anemia

7.2. Diabetes

7.3. Multiple sclerosis

7.4. Rheumatoid

7.5. Crohn's

7.6. Others

8. Global Injectable Drug Delivery Market -Geographic Analysis

8.1. Introduction

8.2. North America

8.2.1. Canada

8.2.2. Haiti

8.2.3. Mexico

8.2.4. USA

8.2.5. Others

8.3. South and Central America

8.3.1. Argentina

8.3.2. Brazil

8.3.3. Chile

8.3.4. Colombia

8.3.5. Venezuela

8.3.6. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. Italy

8.4.4. Russia

8.4.5. Spain

8.4.6. Turkey

8.4.7. U.K

8.4.8. Others

8.5. APAC

8.5.1. Bangladesh

8.5.2. China

8.5.3. India

8.5.4. Nepal

8.5.5. Srilanka

8.5.6. Singapore

8.5.7. Malaysia

8.5.8. Others

8.6. ROW

9. Market Entropy

9.1. New Product Launches

9.2. MandAs, Collaborations, JVs and Partnerships

10. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)

10.1.Becton Dickinson and Company (BD)

10.2.Baxter International Inc.

10.3.Consort Medical PLC

10.4. Crossject SA

10.5. Eli Lilly and Company

10.6. Elcam Medical

10.7. Novo Nordisk

10.8. Owen Mumford Ltd

10.9. Sanofi

10.10. Schott AG

10.11. Terumo Corporation

10.12. Ypsomed Holding AG

10.13. Others

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

11.1.Abbreviations

11.2.Sources

11.3.Research Methodology

11.4.Bibliography

11.5.Compilation of Expert Insights

11.6.Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Needle Free Injection Systems Market by Product, by Technology, Usability, Type of Medication, Delivery Site - Forecasts to 2021

Needle Free Injection Systems Market by Product, by Technology, Usability, Type of Medication, Delivery Site - Forecasts to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 billion by 2021 from USD 9.81 billion in 2016, at a CAGR of 15.5% during the forecast period. The report ...

Syringes Market by Usability & Disposable Syringes), Material, Type - Global Forecast to 2021

Syringes Market by Usability & Disposable Syringes), Material, Type - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The syringes market is expected to reach USD 15.99 billion by 2021, at a CAGR of 8.7% from 2016 to 2021. The syringes market is primarily driven by the high prevalence of chronic diseases across the globe. ...

Drug Delivery Technology Market by Route of Administration, Patient Care Setting - Global Forecast to 2021

Drug Delivery Technology Market by Route of Administration, Patient Care Setting - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The drug delivery technology market is projected to reach USD 1,669.40 billion by 2021 from USD 1,179.20 billion in 2016, at a CAGR of 7.2% during the forecast period. Increasing prevalence of chronic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.